Media headlines about Imperva (NYSE:IMPV) have trended positive on Saturday, according to Accern Sentiment Analysis. The research group rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Imperva earned a news impact score of 0.27 on Accern’s scale. Accern also gave news headlines about the software maker an impact score of 46.2093824839439 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:

A number of equities research analysts have recently weighed in on IMPV shares. Evercore ISI set a $56.00 price objective on Imperva and gave the company a “buy” rating in a research note on Thursday, August 10th. Piper Jaffray Companies set a $58.00 price objective on Imperva and gave the company a “buy” rating in a research note on Monday, August 28th. Monness Crespi & Hardt lifted their price objective on Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a research note on Friday, July 28th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $49.00 price objective on shares of Imperva in a research note on Wednesday, October 18th. Finally, Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and issued a $55.00 price objective on shares of Imperva in a research note on Thursday. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Imperva presently has an average rating of “Hold” and a consensus price target of $52.38.

Shares of Imperva (NYSE:IMPV) traded up $0.60 during midday trading on Friday, reaching $41.20. The company’s stock had a trading volume of 222,500 shares, compared to its average volume of 448,881. Imperva has a 12 month low of $35.45 and a 12 month high of $52.40.

Imperva (NYSE:IMPV) last announced its quarterly earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.11. The company had revenue of $83.89 million during the quarter, compared to the consensus estimate of $83.79 million. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. Imperva’s revenue for the quarter was up 22.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.08 EPS.

In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of Imperva stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the sale, the director now directly owns 99,598 shares of the company’s stock, valued at approximately $4,341,476.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.20% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Insider Buying and Selling by Quarter for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.